Elevated Platelet Count Appears to Be Causally Associated with Increased Risk of Lung Cancer: A Mendelian Randomization Analysis

Background: Platelets are a critical element in coagulation and inflammation, and activated platelets are linked to cancer risk through diverse mechanisms. However, a causal relationship between platelets and risk of lung cancer remains unclear. Methods: We performed single and combined multiple instrumental variable Mendelian randomization analysis by an inverse-weighted method, in addition to a series of sensitivity analyses. Summary data for associations between SNPs and platelet count are from a recent publication that included 48,666 Caucasian Europeans, and the International Lung Cancer Consortium and Transdisciplinary Research in Cancer of the Lung data consisting of 29,266 cases and 56,450 controls to analyze associations between candidate SNPs and lung cancer risk. Results: Multiple instrumental variable analysis incorporating six SNPs showed a 62% increased risk of overall non–small cell lung cancer [NSCLC; OR, 1.62; 95% confidence interval (CI), 1.15–2.27; P = 0.005] and a 200% increased risk for small-cell lung cancer (OR, 3.00; 95% CI, 1.27–7.06; P = 0.01). Results showed only a trending association with NSCLC histologic subtypes, which may be due to insufficient sample size and/or weak effect size. A series of sensitivity analysis retained these findings. Conclusions: Our findings suggest a causal relationship between elevated platelet count and increased risk of lung cancer and provide evidence of possible antiplatelet interventions for lung cancer prevention. Impact: These findings provide a better understanding of lung cancer etiology and potential evidence for antiplatelet interventions for lung cancer prevention.

[1]  A. Abu-Zaid,et al.  Preoperative elevated platelet count and thrombocytosis in gynecologic malignancies , 2018, Archives of Gynecology and Obstetrics.

[2]  N. Meydan,et al.  Role of increased mean platelet volume (MPV) and decreased MPV/platelet count ratio as poor prognostic factors in lung cancer , 2016, The clinical respiratory journal.

[3]  B. Karlan,et al.  Platelets reduce anoikis and promote metastasis by activating YAP1 signaling , 2017, Nature Communications.

[4]  E. Giovannetti,et al.  Swarm Intelligence-Enhanced Detection of Non-Small-Cell Lung Cancer Using Tumor-Educated Platelets , 2017, Cancer cell.

[5]  G. Smith,et al.  Difficulties in Testing the Instrument Strength Independent of Direct Effect Assumption in Mendelian Randomization. , 2017, JAMA cardiology.

[6]  Yvonne Bordon Tumour immunology: Platelets — a new target in cancer immunotherapy? , 2017, Nature Reviews Immunology.

[7]  Ansar Karimian,et al.  The herbal medicine Melissa officinalis extract effects on gene expression of p53, Bcl-2, Her2, VEGF-A and hTERT in human lung, breast and prostate cancer cell lines. , 2017, Gene.

[8]  William S. Bush,et al.  Large-scale association analysis identifies new lung cancer susceptibility loci and heterogeneity in genetic susceptibility across histological subtypes , 2017, Nature Genetics.

[9]  M. Hennig,et al.  Platelets subvert T cell immunity against cancer via GARP-TGFβ axis , 2017, Science Immunology.

[10]  E. Passegué,et al.  The lung is a site of platelet biogenesis and a reservoir for hematopoietic progenitors , 2017, Nature.

[11]  N. Sheehan,et al.  A framework for the investigation of pleiotropy in two‐sample summary data Mendelian randomization , 2017, Statistics in medicine.

[12]  C. Prives,et al.  STXBP4 Drives Tumor Growth and Is Associated with Poor Prognosis through PDGF Receptor Signaling in Lung Squamous Cell Carcinoma , 2017, Clinical Cancer Research.

[13]  Dylan S. Small,et al.  A review of instrumental variable estimators for Mendelian randomization , 2015, Statistical methods in medical research.

[14]  M. Siddiqi,et al.  Single nucleotide polymorphisms, haplotype association and tumour expression of the vascular endothelial growth factor (VEGF) gene with lung carcinoma. , 2013, Gene.

[15]  A. Weyrich,et al.  Platelets in Pulmonary Immune Responses and Inflammatory Lung Diseases. , 2016, Physiological reviews.

[16]  S. Chanock,et al.  Association between Adult Height and Risk of Colorectal, Lung, and Prostate Cancer: Results from Meta-analyses of Prospective Studies and Mendelian Randomization Analyses , 2016, PLoS medicine.

[17]  W. Willett,et al.  Population-wide Impact of Long-term Use of Aspirin and the Risk for Cancer. , 2016, JAMA oncology.

[18]  D. Romić,et al.  Neutrophil-to-lymphocyte and platelet-to-lymphocyte ratio help identify patients with lung cancer, but do not differentiate between lung cancer subtypes , 2016, Croatian medical journal.

[19]  P. Visscher,et al.  Integration of summary data from GWAS and eQTL studies predicts complex trait gene targets , 2016, Nature Genetics.

[20]  L. Dalar,et al.  Are neutrophil/lymphocyte ratio and platelet/lymphocyte ratio reliable parameters as prognostic indicators in malignant mesothelioma? , 2016, Therapeutics and clinical risk management.

[21]  Baolan Li,et al.  Prognostic Value of Basic Fibroblast Growth Factor (bFGF) in Lung Cancer: A Systematic Review with Meta-Analysis , 2016, PloS one.

[22]  N. Nicolay,et al.  Combined inhibition of TGFβ and PDGF signaling attenuates radiation-induced pulmonary fibrosis , 2015, Oncoimmunology.

[23]  Tom R. Gaunt,et al.  Adult height, coronary heart disease and stroke: a multi-locus Mendelian randomization meta-analysis , 2015, International journal of epidemiology.

[24]  J. Menczer Preoperative elevated platelet count and thrombocytosis in gynecologic malignancies , 2016, Archives of Gynecology and Obstetrics.

[25]  K. Pantel,et al.  Tumor-Educated Platelets as Liquid Biopsy in Cancer Patients. , 2015, Cancer cell.

[26]  Tom R. Gaunt,et al.  The effects of height and BMI on prostate cancer incidence and mortality: a Mendelian randomization study in 20,848 cases and 20,214 controls from the PRACTICAL consortium , 2015, Cancer Causes & Control.

[27]  R. Storey,et al.  The role of platelets in inflammation , 2015, Thrombosis and Haemostasis.

[28]  A. Franco,et al.  Platelets at the interface of thrombosis, inflammation, and cancer. , 2015, Blood.

[29]  X. Lang,et al.  Correlation Between MMP-7 and bFGF Expressions in Non-small Cell Lung Cancer Tissue and Clinicopathologic Features , 2015, Cell Biochemistry and Biophysics.

[30]  Aung Ko Win,et al.  Mendelian randomization study of height and risk of colorectal cancer. , 2015, International journal of epidemiology.

[31]  A. Jemal,et al.  Global cancer statistics, 2012 , 2015, CA: a cancer journal for clinicians.

[32]  D. Su,et al.  Elevated platelet count is a strong predictor of poor prognosis in stage I non-small cell lung cancer patients , 2015, Platelets.

[33]  Neil M Davies,et al.  The many weak instruments problem and Mendelian randomization , 2014, Statistics in medicine.

[34]  A. Kıyıcı,et al.  Evaluation of Platelet Indices in Lung Cancer Patients. , 2015, Asian Pacific journal of cancer prevention : APJCP.

[35]  W. Chow,et al.  Risk of esophageal adenocarcinoma decreases with height, based on consortium analysis and confirmed by Mendelian randomization. , 2014, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.

[36]  Eric J Tchetgen Tchetgen,et al.  Methodological Challenges in Mendelian Randomization , 2014, Epidemiology.

[37]  S. Burgess Sample size and power calculations in Mendelian randomization with a single instrumental variable and a binary outcome , 2014, International journal of epidemiology.

[38]  A. Jemal,et al.  Cancer statistics, 2014 , 2014, CA: a cancer journal for clinicians.

[39]  A. Butterworth,et al.  Mendelian Randomization Analysis With Multiple Genetic Variants Using Summarized Data , 2013, Genetic epidemiology.

[40]  Yun Cai,et al.  Activated Platelets Interact with Lung Cancer Cells Through P-Selectin Glycoprotein Ligand-1 , 2012, Pathology & Oncology Research.

[41]  Christian Gieger,et al.  New gene functions in megakaryopoiesis and platelet formation , 2011, Nature.

[42]  J. Y. Park,et al.  Aspirin use and risk for lung cancer: a meta-analysis. , 2011, Annals of oncology : official journal of the European Society for Medical Oncology.

[43]  D. Lawlor,et al.  American Journal of Epidemiology Practice of Epidemiology Instrumental Variable Estimation of Causal Risk Ratios and Causal Odds Ratios in Mendelian Randomization Analyses , 2022 .

[44]  S. Thompson,et al.  Bias in causal estimates from Mendelian randomization studies with weak instruments , 2011, Statistics in medicine.

[45]  Kiyoshi Tanabe,et al.  An Association Between Long-Term Exposure to Ambient Air Pollution and Mortality From Lung Cancer and Respiratory Diseases in Japan , 2011, Journal of epidemiology.

[46]  S. Kligerman,et al.  Epidemiology of lung cancer in women: risk factors, survival, and screening. , 2011, AJR. American journal of roentgenology.

[47]  Yusuke Nakamura,et al.  Genome-wide association study of hematological and biochemical traits in a Japanese population , 2010, Nature Genetics.

[48]  S. Pitchford Novel uses for anti‐platelet agents as anti‐inflammatory drugs , 2007, British journal of pharmacology.

[49]  N. Sheehan,et al.  Mendelian randomization as an instrumental variable approach to causal inference , 2007, Statistical methods in medical research.

[50]  S. Norby [Mendelian randomization]. , 2005, Ugeskrift for laeger.

[51]  N. Ferrara,et al.  The biology of VEGF and its receptors , 2003, Nature Medicine.

[52]  L. Claesson‐Welsh,et al.  FGF and VEGF function in angiogenesis: signalling pathways, biological responses and therapeutic inhibition. , 2001, Trends in pharmacological sciences.

[53]  B. Cohen TESTING A BEIR-VI SUGGESTION FOR EXPLAINING THE LUNG CANCER vs. RADON RELATIONSHIP FOR U.S. COUNTIES , 2000, Health physics.

[54]  A. Jemal,et al.  Global cancer statistics , 2011, CA: a cancer journal for clinicians.

[55]  J. Folkman,et al.  Involvement of platelets in tumour angiogenesis? , 1998, The Lancet.

[56]  H. Verheul,et al.  Platelet: transporter of vascular endothelial growth factor. , 1997, Clinical cancer research : an official journal of the American Association for Cancer Research.

[57]  N. Dubrawsky Cancer statistics , 1989, CA: a cancer journal for clinicians.

[58]  C. Stewart,et al.  Antimetastatic effects associated with platelet reduction. , 1968, Proceedings of the National Academy of Sciences of the United States of America.